Artha Sootra - Company Dashboard

Governance Classic Home

Emcure Pharmaceuticals LtdPharmaceuticalsINE168P01015Consolidated₹2174.55+192.00 (+9.68%)

Valuation

Market Cap₹40.98K Cr

TTM PE37.47x

Forward PE35.61x

PEG4.64

Book Value₹260.97

P/B8.28x

TTM EPS₹57.66

Fwd EPS₹60.67

TTM Revenue₹10.23K Cr

TTM PAT₹1.09K Cr

TTM EBITDA₹2.09K Cr

TTM EBIT₹1.66K Cr

Last Qtr PAT₹325.07 Cr

Last Qtr EBITDA₹587.84 Cr

Last Qtr EBIT₹478.18 Cr

Profitability

ROE22.07%

ROCE25.43%

TTM NPM10.68%

TTM EBITDA %20.45%

Curr OPM11.51%

Last OPM11.33%

Curr NPM—

Last NPM—

Curr EPS₹17.16

Last EPS₹15.50

Balance sheet

Equity₹189.59 Cr

Reserve₹4.76K Cr

Total Debt₹1,521.24 Cr

D/E0.31x

Interest %10.95%

Curr Interest₹35.58 Cr

Price / range

Close₹2160.40

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+9.30%

1W+16.08%

1M+11.88%

3M+9.99%

6M+21.81%

1Y+63.00%

2Y+49.99%

3Y—

5Y—

Diwali+53.95%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	1,667.98+32.3%	1,450.93	1,467.70	1,418.31	1,260.60	5,243.19
Other Income	33.54	25.03	26.94	138.30	22.75	209.52
Total Income	1,701.52+32.6%	1,475.96	1,494.64	1,556.61	1,283.36	5,452.70
Interest	32.42	32.78	36.87	33.15	27.71	118.27
Expenditure	-1,369.15-21.7%	-1,207.29	-1,195.96	-1,213.09	-1,125.47	-4,483.44
PBDT	0	0	0	0	0	0
EBITDA	396.26+76.4%	339.59	371.65	300.51	224.58	1,124.75
Depreciation	-65.01	-63.17	-63.04	-62.14	-61.74	-246.73
EBIT	331.25+103.4%	276.42	308.61	238.37	162.84	878.02
PBT	332.38+110.5%	268.67	306.27	314.37	157.89	944.19
Tax	-83.95	-68.57	-72.57	-55.51	-40.27	-211.23
Equity	189.71	189.68	189.59	189.57	0	189.59
OPM	19.53	18.20	20.49	20.20	12.53	17.32
Net Profit	248.43+111.2%	200.11	233.70	258.85	117.62	732.96
NPM	14.60	13.56	15.64	16.63	9.33	13.44
EPS	13.10+111.0%	10.55	12.33	13.65	6.21	38.67

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	5,243.19+19.7%	4,381.92
Other Income	209.52	118.81
Total Income	5,452.70+21.2%	4,500.73
Expenditure	-4,483.44-10.1%	-4,073.02
Interest	-118.27	-112.96
PBDT	0	0
EBITDA	1,124.75+73.9%	646.83
Depreciation	-246.73	-224.97
EBIT	878.02+108.1%	421.86
PBT	944.19+120.8%	427.71
Tax	-211.23	-110.58
Equity	189.59	189.48
OPM (%)	17.32	9.50
Net Profit	732.96+131.1%	317.13
NPM (%)	13.44	7.05
EPS (Rs)	38.67+128.1%	16.95
CEPS	38.67	16.95

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	2,820.47+24.3%	2,580.45	2,469.70	2,363.48	2,269.82	9,203.54
Other Income	3.25	2.07	3.99	1.85	3.12	12.66
Total Income	2,823.73+24.2%	2,582.52	2,473.70	2,365.33	2,272.95	9,216.20
Interest	35.58	31.54	46.40	37.98	32.54	143.67
Expenditure	-2,377.87-23.1%	-2,188.99	-2,142.82	-2,013.39	-1,931.53	-7,897.71
PBDT	0	0	0	0	0	0
EBITDA	587.84+23.6%	532.51	479.55	492.75	475.47	1,864.55
Depreciation	-109.66	-109.51	-106.27	-104.68	-104.64	-415.05
EBIT	478.18+28.9%	423	373.28	388.07	370.83	1,449.50
PBT	445.85+30.6%	393.53	341.18	313.79	341.42	1,287.14
Tax	-120.78	-101.03	-97.44	-82.42	-90.05	-345.87
Equity	189.71	189.68	189.59	189.57	0	189.59
OPM	15.79	15.24	13.79	13.27	15.02	13.97
Net Profit	325.07+29.3%	292.49	243.74	231.37	251.37	941.27
NPM	11.51	11.33	9.85	9.78	11.06	10.21
EPS	17.16+33.5%	15.50	12.84	12.16	12.85	48.77

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	9,203.54+16.6%	7,896.00
Other Income	12.66	67.26
Total Income	9,216.20+15.7%	7,963.26
Expenditure	-7,897.71-13.1%	-6,981.53
Interest	-143.67	-175.78
PBDT	0	0
EBITDA	1,864.55+26.5%	1,474.38
Depreciation	-415.05	-384.13
EBIT	1,449.50+33.0%	1,090.25
PBT	1,287.14+32.5%	971.35
Tax	-345.87	-263.88
Equity	189.59	189.48
OPM (%)	13.97	12.20
Net Profit	941.27+33.0%	707.47
NPM (%)	10.21	8.88
EPS (Rs)	48.77+33.9%	36.43
CEPS	48.77	36.43

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	3.6	04 Sep 2026
2025	Final Dividend	3	14 Aug 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split